Skip to main content

AIGH Capital Management LLC

Position in APRE — Aprea Therapeutics, Inc.

CIK 1835943 BALTIMORE, MD

Position in APRE

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$814,463
+$39,606 QoQ
Shares Held
1,015,541
0.0% QoQ
Ownership
8.07%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1
of 28 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 90% Shared 10% None 0%

Common Shares in APRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AIGH Capital Management LLC holds $149,698,985 across 14 Biotechnology names. APRE ranks #13 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APRE

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $814,463 1,015,541
2026-03-31 $774,857 1,015,541
2025-12-31 $316,071 370,541
2025-09-30 $795,467 539,300
2025-06-30 $911,416 539,300
2025-03-31 $1,100,171 539,300
2024-12-31 $1,774,296 539,300
2024-09-30 $1,483,074 539,300
2024-06-30 $2,194,950 539,300
2024-03-31 $3,607,916 539,300
2023-12-31 $1,641,709 349,300
2023-09-30 $1,455,532 349,300
2023-06-30 $1,100,294 349,300
2023-03-31 $1,531,799 345,000